Toradol and Joint effusion - a phase IV clinical study of FDA data

Summary:

Joint effusion is reported as a side effect among people who take Toradol (ketorolac tromethamine), especially for people who are female, 50-59 old, also take Percocet, and have Metastases to bone.

The phase IV clinical study analyzes which people have Joint effusion when taking Toradol. It is created by eHealthMe based on reports of 8,757 people who have side effects when taking Toradol from the FDA, and is updated regularly.

What is Toradol?

Toradol has active ingredients of ketorolac tromethamine. It is often used in pain. eHealthMe is studying from 9,230 Toradol users. Check the latest studies of Toradol.

What is Joint effusion?

Joint effusion (presence of extra fluid in joint covering) is found to be associated with 868 drugs and 750 conditions by eHealthMe. Check the latest studies of Joint effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

8,757 people reported to have side effects when taking Toradol.
Among them, 32 people (0.37%) have Joint effusion.

Among these 32 people:

What is the gender of people who have Joint effusion when taking Toradol? *

female: 76 %
male: 24 %

What is the age of people who have Joint effusion when taking Toradol? *

What are other drugs people take besides Toradol? *

What are other side effects people have besides Joint effusion? *

Joint Pain: 24 people, 75.00%
Stress And Anxiety: 22 people, 68.75%
Urinary Tract Infection: 17 people, 53.12%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 50.00%
Headache (pain in head): 16 people, 50.00%
Colitis (inflammation of colon): 16 people, 50.00%
Weakness: 16 people, 50.00%
Osteonecrosis Of Jaw (death of bone of jaw): 15 people, 46.88%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 15 people, 46.88%
Osteoporosis (bones weak and more likely to break): 14 people, 43.75%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 31.25%
Metastases To Bone (cancer spreads to bone): 10 people, 31.25%
Breast Cancer: 7 people, 21.88%
Depression: 5 people, 15.62%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 9.38%
Gastric Disorder (disease of stomach): 3 people, 9.38%
High Blood Pressure: 3 people, 9.38%
Stress And Anxiety: 3 people, 9.38%
Toothaches (tooth pain): 2 people, 6.25%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Toradol and have Joint effusion?

- Check whether Joint effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Toradol:

Toradol (9,230 reports)

Joint effusion treatments and more:

Joint effusion (9,947 reports)

Browse all side effects of Toradol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint effusion:

Joint effusion (868 drugs)

Browse all the conditions that are associated with Joint effusion:

Joint effusion (750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine (the active ingredients of Toradol) and Toradol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.